Esperion Announces Presentation of Bempedoic Acid Pivotal Phase 3 Study 2 Results in a Late-Breaking Clinical Trial Session at the American College of Cardiology 2019 Scientific Sessions March 4, 2019 - NASDAQ Companies 0 » View More News for March 04, 2019
